Unwrapping the new pharmaceutical legislation

This week, EURACTIV’s health team dives into the proposal for a new pharmaceutical legislation and the complicated way ahead. For that, they talk with stakeholders working on health policy at the EU level about their priorities and main concerns.

We spoke with the Executive Director for strategy and healthcare systems at the European Federation of Pharmaceutical Industries and Associations (EFPIA) Thomas Allvin, the Executive Director at Medicines for Europe Adrian van den Hoven, the Director of the European Social Insurance Platform (ESIP) Yanis Natsis, and European Public Health Alliance (EPHA) Director General Milka Sokolovic.